MVIR:STO
Medivir AB
SEK 1,64
arrow_downward
-0,36%(-0,0060) 1 HR
30 Sep, 17.29.42 GMT+2 · SEK
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk MVIR...
Pembukaan
SEK 1,66
Tinggi
SEK 1,69
Rendah
SEK 1,62
Kapitalisasi pasar
1,02 M
Volume rata-rata
1,95 jt
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
SEK 2,88
Harga rendah dalam 52 minggu terakhir
SEK 0,34
EPS
-SEK 0,37
Saham beredar
624,04 jt
Jumlah karyawan
6
Pembukaan
SEK 1,66
Tinggi
SEK 1,69
Rendah
SEK 1,62
Kapitalisasi pasar
1,02 M
Volume rata-rata
1,95 jt
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
SEK 2,88
Harga rendah dalam 52 minggu terakhir
SEK 0,34
EPS
-SEK 0,37
Saham beredar
624,04 jt
Jumlah karyawan
6
Artikel berita
Dari sumber web dan partner berita
TradingView
·
7 jam yang lalu
Number of shares and votes in Medivir AB on September 30, 2026
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Tentang Medivir AB